Tesamorelin

Tesamorelin 5mg

For laboratory research use only. Not for human consumption.

Key Benefits

• Visceral adipose tissue (VAT) reduction pathways
• Stimulation of endogenous growth hormone release
• Downstream increases in insulin-like growth factor-1 (IGF-1)
• Metabolic and lipid regulation research
• Body composition and lean mass preservation research
• Pituitary and endocrine signalling research

Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analogue studied for its role in stimulating endogenous growth hormone secretion. In research settings, it has been explored in relation to visceral adipose tissue, metabolic regulation, and endocrine signalling pathways.

Tesamorelin functions upstream of growth hormone release, supporting natural pulsatile secretion rather than introducing exogenous growth hormone.

Because it promotes endogenous hormone release rather than supplying external growth hormone, Tesamorelin is researched for its potential to support physiological feedback loops and natural endocrine rhythms.

Product Details

• Quantity: 5mg lyophilised peptide powder
• Form: Sterile research-grade vial
• Storage: Keep refrigerated (2–8°C). Temporary room-temperature exposure during transit is acceptable.
• Reconstitution: Using sterile bacteriostatic or laboratory-grade water (per researcher protocol).

Legal & Compliance

This product is supplied strictly for laboratory, scientific, and in-vitro research only.
Not for human use, medical use, diagnostic use, or veterinary use.
No health, therapeutic, or medical claims are made about this peptide.